Search the Newsreel

16-Time X Games Medalist Jarryd McNeil Joins BUZZ BOMB

Aspire Biopharma's subsidiary, Buzz Bomb Caffeine Company, has signed 16-time X Games medalist Jarryd McNeil as a Global Brand Ambassador for its BUZZ BOMB™ single-serve caffeine powder line. McNeil will promote the brand across his tours, competitions, and social media, while BUZZ BOMB™ aims …

Aspen Pharmacare Canada receives Health Canada approval for a generic equivalent of Ozempic®

New generic equivalent of Ozempic® expected to help expand access to semaglutide treatment options for adults with type 2 diabetes in Canada OAKVILLE, ON, July 21, 2026 /CNW/ -- Aspen Pharmacare Canada Inc., a subsidiary of Aspen Pharmacare Holdings Limited ("Aspen"), today announced that …

ASP Isotopes partners with Texas A&M to enhance uranium hexafluoride production

ASP Isotopes (ASPI) has partnered with Texas A&M Engineering Experiment Station (TEES) through its subsidiary, Quantum Leap Energy, to advance the production of high-purity uranium hexafluoride (UF6). This collaboration aims to improve production efficiency, lower costs, and strengthen the domestic nuclear fuel supply chain, …

ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology

ASP Isotopes Inc. (ASPI) announced that its subsidiary, Quantum Leap Energy (QLE), has partnered with the Texas A&M Engineering Experiment Station (TEES) to advance uranium conversion technology. This collaboration aims to develop scalable domestic production of high-purity uranium hexafluoride (UF6), a crucial component for …

Quantum Leap Energy Studies Turning Yellowcake Into Nuclear Fuel Feedstock

ASP Isotopes' subsidiary, Quantum Leap Energy (QLE), has partnered with the Texas A&M Engineering Experiment Station (TEES) to advance uranium conversion technology, focusing on transforming yellowcake uranium into high-purity uranium hexafluoride (UF6). This collaboration aims to improve production efficiency, reduce costs, and enhance the …

Caspian Sunrise Stock Price Forecast. Should You Buy CASP.L?

Aspire Biopharma Holdings, Inc. 8-K — Jul 20, 2026

MLQ.ai reported on an 8-K filing by Aspire Biopharma Holdings, Inc., dated July 20, 2026. This filing is categorized under "Other events" and is accessible directly on SEC.gov. The platform MLQ.ai provides research, news, and data related to frontier tech and financial filings.

Jasper Therapeutics (JSPR) director details common and preferred stake

Patrick J. Crutcher, a director at Jasper Therapeutics (JSPR), reported his holdings of 518,331 shares of Voting Common Stock and 463,452 shares of Non-Voting Convertible Preferred Stock. The preferred stock is convertible into 61 shares of common stock upon stockholder approval, subject to a …

Jasper Therapeutics (JSPR) director buys preferred stock, granted stock options

Patrick J. Crutcher, a director at Jasper Therapeutics, Inc. (JSPR), recently acquired 888 shares of Non-Voting Convertible Preferred Stock via a private placement on July 20, 2026. These preferred shares will convert into 61 shares of Voting Common Stock each, after stockholder approval, subject …

Aspire Bi clarifies public warrant terms after two reverse stock splits; exercise price now $13,800

Aspire Biopharma (ASBP) has clarified the terms of its public warrants following two reverse stock splits. The exercise price for these warrants is now $13,800, and the conversion ratio has been adjusted to 1,200 warrants per share of common stock. These changes result from …

Aspen Aerogels stock trades around recent lows as margin pressure offsets revenue growth

Aspen Aerogels Inc. (ASPN) shows a mixed financial picture with strong revenue growth in 2023 and early 2024, driven by demand for its aerogel products in battery and industrial markets. However, the company continues to report net losses and suffers from margin pressure due …

Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM)

Aspire Biopharma Holdings, Inc.'s subsidiary Buzz Bomb Caffeine Company LC has announced a partnership with multi-time X Games medalist and freestyle motocross legend Jarryd McNeil. McNeil will serve as a global brand ambassador for the BUZZ BOMB™ caffeine product line, integrating the branding into …

Jasper Therapeutics merges with Kira Pharmaceuticals

Jasper Therapeutics has completed an all-stock acquisition of Kira Pharmaceuticals, forming a combined entity focused on developing biologic agents for immunologically-driven conditions. The deal is backed by a $132 million private placement and an out-licensing agreement with Mirador Therapeutics, expected to fund operations through …

Jasper Therapeutics stock trades sideways as cash position and clinical pipeline shape outlook

Jasper Therapeutics (JSPR) is an early-stage biotech company trading on Nasdaq, with its stock performance closely tied to its cash reserves, burn rate, and the progress of its clinical pipeline. The company is developing CD117-targeted conditioning agents for hematopoietic stem cell transplantation and gene …

Enterprise value to EBIT forward of Aspen Aerogels, Inc. – NYSE:ASPN

This article displays the "Enterprise value to EBIT forward" metric for Aspen Aerogels, Inc. (NYSE: ASPN) on the TradingView platform. It presents the value and change over a period, indicating it's a financial data point for the company. The content primarily focuses on presenting …

Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company

ASP Isotopes Inc. and ENDRA Life Sciences Inc. announced an investor webinar for Noble Africa, a proposed spin-out set to become a Nasdaq-listed public helium company under the ticker "NOBA." The webinar, hosted by RedChip Companies, will feature Paul Mann, CEO of ASP Isotopes …

ASP Isotopes (ASPI) converts $109M in subsidiary notes into common stock

ASP Isotopes Inc. (ASPI) has completed an exempt securities offering under Regulation D, Rule 506(b), converting $109,181,606 of aggregate principal and accrued unpaid interest from subsidiary convertible promissory notes into ASP Isotopes common stock. This debt-for-equity exchange resulted in the issuance of 23,160,682 common …

Jasper gets a lifeline in merger with immune drugmaker Kira

Cash-strapped Jasper Therapeutics has merged with privately held Kira Pharmaceuticals in an all-stock acquisition, securing a $132 million private stock offering that extends its operational runway through 2028. This deal allows Jasper to rebound from previous setbacks and expand its pipeline with two immune …

ASPN stock rises on fresh 2026 report context

ASPN stock is seeing an uptick due to the context of its 2026 report, which relies on Aspen Aerogels' latest financial filings. The company reported a 23% revenue increase to $441.0 million in fiscal 2025, alongside a narrowed net loss of $107.7 million, showing …

Jasper Closes Kira Deal, Extends Cash Runway

Jasper Therapeutics has completed its all-stock acquisition of Kira Pharmaceuticals, enhancing its pipeline of therapies for immune-mediated diseases. This merger, combined with a $132 million private placement, extends Jasper's cash runway through the second half of 2028. The company plans to advance several key …

12 Health Care Stocks Moving In Friday's Intraday Session

This article lists 12 health care stocks experiencing significant price movements during Friday's intraday trading. It details six gainers, including Jasper Therapeutics and Kalaris Therapeutics, with their percentage increases, stock prices, and market capitalizations. The article also covers six losers, such as Agape ATP …

Is ASP Isotopes' (ASPI) New Shelf Registration Reframing Its Long‑Term Capital Strategy?

ASP Isotopes Inc. recently filed a shelf registration to issue up to US$106.08 million in common stock, highlighting the company's expected ongoing capital needs and increasing the likelihood of future equity issuance. This move allows the company to quickly access equity capital, which is …

Noble Africa's helium project could become a Nasdaq-listed company

ASP Isotopes (NASDAQ:ASPI) and ENDRA Life Sciences (NASDAQ:NDRA) are hosting an investor webinar on July 21, 2026, to discuss the proposed merger of Noble Africa with ENDRA. This merger is anticipated to result in Noble Africa, which is the holding company for Renergen’s Virginia …

Patrick Crutcher appointed to Jasper Therapeutics board; Matthew Ros named COO

Jasper Therapeutics (JSPR) has announced two key appointments: Patrick Crutcher to its board of directors and Matthew Ros as Chief Operating Officer. These changes are effective immediately following the Effective Time on July 16, 2026, and are in accordance with a merger agreement. Both …

Jasper Therapeutics (NASDAQ: JSPR) buys Kira, adds $132M PIPE cash

Jasper Therapeutics (NASDAQ: JSPR) announced the all-stock acquisition of Kira Pharmaceuticals and concurrently secured $132 million in PIPE financing. This strategic move is expected to significantly dilute pre-transaction Jasper equity holders but aims to fund multiple clinical milestones and operating needs through the second …

Jasper buys time with Kira merger and $132M PIPE lifeline

The article discusses Jasper's merger with Kira and a $132 million PIPE (Private Investment in Public Equity) lifeline. This strategic move aims to provide Jasper with additional resources and time, addressing financial challenges and enhancing its market position. The merger and investment are critical …

Jasper Therapeutics posts investor presentation on Kira merger, PIPE financing and immunology pipeline strategy

Jasper Therapeutics has released an investor presentation detailing its all-stock merger with Kira Pharmaceuticals, accompanied by a $132 million PIPE financing. The deal outlines an ownership split favoring legacy Kira holders and PIPE investors, with Jasper holders receiving a contingent value right. Proceeds from …

Jasper Therapeutics completes Kira acquisition, secures $132M financing to fund pipeline into H2 2028

Jasper Therapeutics has completed an all-stock acquisition of Kira Pharmaceuticals and concurrently secured $132 million in financing. This funding, along with proceeds from out-licensed assets, is expected to finance combined operations and multiple clinical milestones through the second half of 2028. The company plans …

Jasper Merger Brings Three Drug Candidates for Immune Disorders

Jasper Therapeutics has completed an all-stock acquisition of Kira Pharmaceuticals, creating a combined company focused on developing biologic therapies for immunologically-driven disorders. Concurrently, Jasper secured approximately $132 million in a private placement and out-licensed two assets for $12 million, extending its cash runway through …

Press Release: Jasper Therapeutics Announces Merger With Kira Pharmaceuticals

Jasper Therapeutics and Kira Pharmaceuticals have announced a definitive merger agreement. The combined company will focus on advancing Kira's pipeline of complement-guided therapies for immune-mediated diseases, including a lead asset, KP104, nearing Phase 3 trials. The merger aims to create a clinical-stage biotechnology company …

ASP Isotopes | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

This document is an S-3ASR filing, which is an automatic shelf registration statement for securities of well-known seasoned issuers. This type of filing allows eligible companies to register a wide range of securities on a continuous or delayed basis.

ASP Isotopes (Nasdaq: ASPI) resale shelf for 23,160,682 shares

ASP Isotopes Inc. has registered the resale of 23,160,682 shares of common stock by certain selling stockholders. These shares were issued in exchange for $109,181,606 of 8% Convertible Promissory Notes from its subsidiary, Quantum Leap Energy LLC, plus accrued interest. The company will not …

ASP Isotopes Swaps $109.2M QLE Convertible Notes for 23.16M Shares to Deleverage

ASP Isotopes has entered into agreements to exchange approximately $109.2 million of Quantum Leap Energy 8.0% Convertible Notes for over 23 million newly issued common shares. This debt-for-equity swap aims to reduce the company's debt burden and strengthen its capital structure. The transactions are …

ASP Isotopes (NASDAQ: ASPI) cuts QLE debt 50% via $109.2M note-for-stock deal

ASP Isotopes Inc. (ASPI) has announced a deal to exchange approximately $109.2 million of convertible promissory notes from its wholly-owned subsidiary, Quantum Leap Energy (QLE), for about 23.2 million shares of ASPI common stock. This transaction is expected to reduce QLE's outstanding convertible debt …

XY78 Bond Profile — Key Metrics

This article provides key metrics for the XY78 bond issued by Kaspi.kz Joint Stock Company. It details the bond's coupon rate, issue and maturity dates, outstanding and face values, and minimum denomination. The company overview highlights Kaspi.kz's operating segments: Payments Platform, Marketplace Platform, and …

Jasper Therapeutics (NASDAQ: JSPR) closes Kira merger and $132M preferred financing

Jasper Therapeutics (NASDAQ: JSPR) has completed its all-stock acquisition of Kira Pharmaceuticals and secured approximately $132 million in preferred stock financing. This merger combines Kira's complement-therapy assets (KP-104, KP-701) with Jasper's briquilimab program, creating a consolidated pipeline focused on immunologically-driven disorders. The financing, along …